02 Jan 2026 16:55 CET

Issuer

Lifecare ASA

The Extraordinary General Meeting of Lifecare ASA was convened as a hybrid
meeting on 2 January 2026.

All proposals on the agenda were adopted, cf. the notification of the
Extraordinary General Meeting that was published on Oslo Stock Exchange on 11
December 2025. The complete minutes of the Extraordinary General Meeting are
attached and are also available on https://lifecare.no/investor/governance/

About us
Lifecare ASA is a medical sensor company developing technology for sensing and
monitoring of various body analytes. Lifecare's focus is to bring the next
generation of Continuous Glucose Monitoring systems to market. Lifecare
enables osmotic pressure as sensing principle. Lifecare's sensor technology is
suitable for identifying and monitoring the occurrence of a wide range of
analytes and molecules in the human body and in pets.

Contacts
For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42

This information is subject to disclosure under the Norwegian Securities
Trading Act, §5-12. The information was submitted for publication, through the
agency of the contact persons set out above, at 2026-01-02 16:55 CET.


663041_Minutes EGM 2 January 2026.pdf
663041_LIFECARE ASA- Minutes from Extraordinary General Meeting.pdf

Source

Lifecare ASA

Provider

Oslo Børs Newspoint

Company Name

LIFECARE ASA

ISIN

NO0013355859

Symbol

LIFE

Market

Euronext Oslo Børs